Pharma’s Search for Operational Truth

Integration of control and business information technologies are opening new windows of enterprise transparency

dec homepage

As with any contemporary, complex manufacturing enterprise, information technology (IT) is a key, critical element crucial to effective and efficient operations. This is especially true for Pharma and Life Sciences. Of course it is, just ask any traditional IT operative in your organization; they’re sure to tell you the whole place would come to a screeching halt without their expert guidance and technology. Pride aside, it’s more or less fact. The digital age has introduced much in the way of game-changing technology to the “business” side of the house, including fundamental protocols, pervasive enterprise resource planning (ERP) platforms, and all those…

Full Story

Don't Miss These Pharma Manufacturing Exclusives


On-demand, concise audio and powerpoint tutorials on the fundamental concepts of pharmaceutical manufacturing, process development, quality control and compliance.

Ask the Expert

We've assembled a roster of leading authorities in many fields to help you address technical issues. Pose a question or browse previous questions to find helpful answers.

Funny Pharm

Write a caption and win!

Aug15homepageBe sure to check out our newest cartoon created by award-winning artist Jerry King. He provides the artwork; you provide the funny caption!

Most Recent

  • Regulatory Resolutions

    As is tradition, the FDA’s Center for Drug Evaluation and Research (CDER) sends their publicity staff to corner the director to discuss major events from the year past and goals for the New Year. Dr. Janet Woodcock recently posted her thoughts and aspirations on her Director’s Corner blog.

    Full Story
  • Germany’s Solid Dose PowerHouse: Rottendorf

    By Steven E. Kuehn, Editor in Chief

    Rottendorf Pharma USA’s president and CEO Gordon Haines noted in a recent website blog that there are three aspects of contract pharma that are virtually universal and most are likely to agree. Worldwide, he said, pharma companies are outsourcing older product production and allocating internal…

    Full Story
  • Toward Real-Time Release at Rutgers

    By Emil W. Ciurczak, Contributing Editor

    RutgersEngineeringCenter for Structured Organic Particulate Systems (C-SOPS center) in New Brunswick recently opened its doors to Pharmaceutical Manufacturing for a first-hand look at its CM research program. The result of a close collaboration with Janssen and a number of academic, public and…

    Full Story
  • Pharma’s Landscape is Going to Look a Lot Different in 2026

    By Girish Malhotra, PE, EPCOT International

    Although the future is difficult to predict, if we observe what is happening around us carefully, the tea leaves can be read with enough clarity to make some plausible projections. Most veteran Pharma observers, me included, might say reading such leaves for the companies and others working…

    Full Story
  • Power Moves: Contract Services' Success Strategies

    By Steven E. Kuehn, Editor in Chief

    Contract services organizations are pursuing a number of strategies to be successful, competitive and relevant to their customers. To get there, this important Pharma sector is driving manufacturing and process innovation at an impressive pace. Critics may argue that compared to other industries…

    Full Story
  • Quality Control with Handheld Raman

    By Claire Dentinger, Applications Scientist, Rigaku Analytical Devices

    Raw material identification (RMID) is a critical step for ensuring compliance with Good Manufacturing Processes (GMPs) and safeguarding the quality of pharmaceutical products. Increasingly strict regulatory requirements for RMID mean that pharmaceutical manufacturers are under increasing pressure…

    Full Story

Latest Products